CAS: 63921-23-3; 1-Phenylpiperidin-4-Amine

上下游产品

CAS号7402-94-0 N-(1-phenyl-4-p... | CAS号19125-34-9 N-苯基-4-哌啶酮 | CAS号3592-25-4 1,5-二氯-3-戊酮 | CAS号94635-24-2 1-(4-甲氧基苯基)哌啶-4-酮

📜1-(4-甲氧基苯基)哌啶-4-酮置于盐酸羟胺,Potassium Carbonate体系中,用 乙醇,水 作为反应溶剂,化学反应生成 1-苯基哌嗪
参考文献:Stepwise Versus Direct Long-Range Charge Separation In Molecular Triads
标题:Stepwise Versus Direct Long-Range Charge Separation In Molecular Triads
摘要:Trifunctional Electron Donor-Donor-Acceptor Molecules Are Described In Which Photoinduced Charge Separation,D-2-D-1-A*--> D-2-D-1(+)-A(-),Is Followed By A Charge Migration Step D-2-D-1(+)-A(-) (Cs1)--> D-2(+)-D-1-A-(Cs2),Leading To A Relatively Long-Lived Charge-Separated State. The Rate Of The Charge Migration Process Could Be Determined In A Range Of Solvents Of Low Polarity. In Benzene And Dioxane,Reversibility Of The Process Allowed The Determination Of The Free Energy Difference Between Cs1 And Cs2. The Relative Energy Of The Cs2 State Is Much Lower Than Expected From Simple Electrostatic Models. An Increase Of The Charge Migration Rate Was Found With Increasing Solvent Polarity Within A Series Of Alkyl Ethers Or Alkyl Acetates. However,An Apparent Preferential Stabilization Of The Cs1 State In Acetates Relative To Ethers Leads To Discontinuities In The Solvatochromic Shift Behavior Of The Ct Fluorescence From The Cs1 State,And In The Increase Of The Charge Migration Rate As A Function Of Dielectric Constant. In A Reference Compound Lacking The Intermediate Redox Unit,Direct Long-Range Charge Separation Yielding A D-2(+)-Bridge-A(-) Charge-Separated State Can occur,But The Yield Is Significantly Lower Than In The Triads.
DOI:10.1021/ja983716R

专利信息

专利号:CN-1552699-A
优先权日:2003-05-30
标题:Synthesis of benzoxazine monohydrochlorate compound

专利号:CN-1262548-C
优先权日:2003-05-30
标 题 :Synthesis of benzoxazine monohydrochlorate compound

专利号:US-5317015-A
优先权日:1992-05-01
标题 :Azacyclic bisphosphonates as anticholesterolemic agents
发明人：ULLRICH JOHN W; YOUSSEFYEH RAYMOND D; CHENEY DANIEL L; BURNS CHRISTOPHER J
权利人:RHONE POULENC RORER PHARMA
摘要:This invention relates to a method of lowering abnormally high serum cholesterol levels in the body without significantly reducing mevalonic metabolite synthesis and to novel pharmacological compositions containing as an active ingredient bisphosphonic acid and ester compounds containing a mono-, bi- or tricyclic ring linked with a bisphosphonate moiety through a basic amino alkylene group. This invention also provides novel bisphosphonate compounds and the processes for their preparation.